# A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan

> clinical trial · VERIFIED · 2026-08-27

Status: NOT_YET_RECRUITING · Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. · Condition: Colorectal Cancer

- Company: Sichuan Baili Pharmaceutical Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07730489

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.